Russian lab unveils cancer vaccine release target

Personalized treatment could begin “within months,” according to the Gamaleya Center’s director Russia’s first patients could begin receiving a newly developed cancer vaccine within the next few months, Alexander Gintsburg, director of the Gamaleya Research Institute of Epidemiology and Microbiology, has announced. The breakthrough drug is a personalized, AI-assisted, mRNA-based vaccine designed to target malignant […]